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INTRODUCTION
In most developing countries of Africa, 70-79% of
breast cancer patients still present with advanced
disease. This makes survival very few and
compromises the quality of life and treatment offered
to these patients. The late presentation is often
ascribed to lack of screening programs, poor breast
awareness and other social factors that mitigate
against early presentation by patients. Since mass
screening with mammography is impracticable in
resource limited environments, breast cancer
prevention and control programs rely on
interventions to increase breast awareness through
mass education, breast self examinations and clinical
breast examination. While such programs work to
improve patient's response to the presence of breast
symptoms, their success also depend on the response
of health care personnel and institutions to patients
presenting with breast problems and the contribution
of each of these to the delay in diagnosis and
treatment.
Nigeria has one of the highest burdens of breast
cancer in Africa but there is no study that has
specifically examined the extent of delays or the
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breast cancer so as to guide policy and intervention
programs aimed at earlier diagnosis and treatment.
This study was designed to assess delays and define
the causes of delays in getting medical treatment by
breast cancer patients at University of Nigeria
Teaching Hospital Enugu, (UNTH-E), Nigeria.
This was a cross-sectional study involving the direct
administration of a semi structured questionnaire to
consecutively presenting breast cancer patients at the
Surgical Oncology unit of the UNTH-E, Nigeria
from June 1999 to May 2005.
All cancer patients managed in the surgical oncology
unit of UNTH-E, Nigeria from June 1999 to May
2005 were recruited into the study as long as they
consented to give the required information. Patient
recruitment was interrupted from June 2001 to April
2003 during the absence of the investigator. Patients
whose condition precluded the ability to give
informed consent were excluded from the study.
Patients were recruited and interviewed
consecutively as they presented at the clinics and
wards. Information about the research was given
verbally to each patient; those that gave consent were
then interviewed. Each patient was assured that the
information sought was not part of the treatment and
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To assess the delays and define the causes of delay in presentation and treatment of breast cancer
patients in Enugu, Nigeria.
Across-sectional survey of breast cancer patients using a semi structured questionnaire.
Surgical Oncology unit, University of Nigeria Teaching Hospital Enugu, (UNTH-E), Nigeria.
164 consecutively presenting breast cancer patients seen between June 1999 and May 2005.
Most of the patients (82.3%) reported for initial evaluation at a modern health facility while 17.5%
reported first to Alternative practitioners. Forty six patients (26.4%) presented within a month of noticing the
symptoms while 72 (45.3%) delayed more than 3 months. In contrast, 18 (17%) were seen at the site of
definitive treatment within one month of seeking help at the initial hospital while 73.4% had a delay of more
than 3 months after the initial hospital contact. Institutional or physician induced delays were present in 46.2%
of the cases while patient related delays were present in 79.2% of cases. Only use of alternative practitioners for
initial treatment was significantly related to delays of more than three months before presentation (p= 0.017).
For breast cancer prevention programs in Nigeria to succeed, they must in addition to breast
awareness and screening programs, address the institutional bottlenecks, the dearth of knowledge among
primary care physicians and improve referrals from alternative practitioners and prayer houses.
Breast cancer, delayed presentation, treatment, Nigeria.
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patients (3.7%) can access a hospital only by going
outside their town of residence. The majority of the
patients, 93 (82.3%) sought initial evaluation at a
modern health facility, 15 patients (13.1%) used
traditional healers and alternative practitioners while
5 patients (4.4%) sought prayer house treatment. The
first point of contact with modern medical treatment
is the general practitioner in over 50% of cases (81).
More than a quarter of the patients (41) initially
consulted a surgeon, 16 patients (10.1%) used a
patent medicine dealer, 12 patients (7.5%) consulted
an Obstetrician Gynaecologist while 8 patients
(5.0%) contacted a nurse or other allied health care
personnel. Ninety four percent of the patients (147)
have passed through one or more physicians before
presenting to us for definitive care while 13% of them
have seen 3 or more physicians. Nine patients (5.5%)
have been commenced on a form of definitive
treatment elsewhere before presentation in our
center.
The lag time from the point patient first noticed the
symptom to presentation for initial evaluation is
shown in table 2. More than 26% of the patients
presented within a month of noticing the symptoms,
54.7% presented within 3 months, while 45.3%
delayed for more than 3 months. In contrast, 71.9%
(110) presented to us for definitive treatment after
delays of over 6 months (Table2). When we
examined the interval between the first hospital of
contact and commencement of definitive treatment
of the breast cancer (whether in our center or
elsewhere), 17% started getting treatment within one
month of reporting at the first hospital, 27.6% were
commenced on treatment within 3 months while
72.4% had a delay of more than 3 months after the
initial hospital contact and 56.4% had delays of more
than 6 months. Most of the patients (78.3%)
presented with stages III and IV disease (Table 3).
Forty one patients (39%) noticed the breast problem
while bathing or dressing, 36 (34.3%) noticed it while
doing breast self examination. The onset of pain
called attention to the problem in 25 (23.8%) of the
respondents. The respondent's spouse or partner
detected the problem in only one percent of cases.
Table 4 shows the reasons the patients gave for delays
in presenting for evaluation at the first health facility.
The majority, 27.8% did not consider the symptoms
serious or thought it will disappear, 23.3% did not
know the implication of the abnormality, 13.9%
lacked finance to go for treatment, 12.6% were
delayed by treatment at alternative practitioners and
prayer houses while 12% did not experience pain and
therefore did not present earlier. The main reasons
that induced our patients to present for treatment
were pain (30.3%), development of features of
locally advanced disease like ulceration, skin
nodules, nipple discharge (22.6%), on the advice of
would in no way influence the treatment of their
cancer. Patients were free to decline answering any
of the question items. The questionnaires were
administered by the investigator or one of his house
staff.
The questionnaire was designed after an extensive
literature search on delays in cancer management. It
was validated with a small group of breast cancer
patients to ensure clarity and consistency. The
questionnaire included demographic data, such as
age, sex, marital status, socioeconomic status,
profession, religious affiliation, area of domicile,
nearest access point for medical treatment and
highest level of education attained. Information on
the stage of the disease were obtained or cross
checked from the case notes. Other information
obtained were symptoms present, how the disease
was noticed, patient's reason for searching for
treatment, the first point patient went for treatment,
the outcome of the initial treatment, the first point for
conventional medical treatment, the lag time
between the onset of symptoms and the first point of
presentation for modern medical treatment, the
reasons for the delay in presenting to the first point of
treatment. The patients were also asked about their
reasons for delay in going to the 1 hospital for
treatment, the duration between presentation at the
first point of treatment and presentation to us, the
reasons for the delay in coming to us for treatment.
We also assessed the awareness of the patient for
methods of early detection of breast cancer and
which screening methods patient has used. An
inquiry was made of past history of breast diseases or
cancer in the patients, among the patient's family or
friends, how it was treated and the outcome of that
treatment as well as patient's beliefs about the cause
of the current problem.
The patients were classified into those with
significant delays (more than 3 months delay) and
those without significant delays (less than 3 months
delay). The two groups were compared with respect
to demographic characteristic and other factors that
influence the outcome of breast cancer treatment.
The data were analyzed using SPSS statistical
software version 9.0. Chi square and student's t-
distribution were used for comparison between the
two groups, with the level of significance at p = 0.05.
A total of 164 breast cancer patients participated in
the study. There were 162 females and 2 males, the
ages range from 21years to 77 years with a mean age
of 45.7yrs and median age of 45years. Other
demographic characteristics are shown in table 1.
A hundred and four patients (96.3%) had access to a


















Less than 1 month 42 26.4 9
5.6
One - 3 months 45 28.3 7 4.3
More than 3 month - 6
months
28 17.6 28 17.3
More than 6 months 44 27.7 118 72.8
Total 159 100 162 100






Marital status Married 116 71.2




























friends and relations (16.3%), patients became
generally worried about the anomaly (12.7%) and
following advice of doctors or other health care
workers (11%).
Age, socioeconomic status, minimum level of
education attained, marital status, religious
affiliation, urban or rural domicile and ease of access
to hospitals did not influence time of initial
presentation of the patients. The two male patients
in the study population were among those that
delayed more than 3 months. Patients who used
alternative practitioners and prayer houses as their
initial point of treatment were significantly more
among those that delayed more than 3 months (21
out of 27 Vs. 36 out of 91, P= 0.017). Patients who
claimed they have used one or more breast cancer
screening methods were slightly more among those
that presented before three months compared to
patients who have never used any screening method
(P = 0.77). Prior history of breast disease, history of
breast cancer among families and friends, how the
cancer or breast disease were treated and outcomes
of such treatments as well as patient's beliefs about
the cause of the breast cancer did not influence the
time of presentation. Stages III and IV disease
occurred more in patients that had more than 3
months delay before definitive treatment (p< 0.001),
(Table 6).
Both patients related and provider induced delays
coexisted in many of the patients that had significant
total delays (Table 5). There were institutional or
physician related delays in 46.2% of the cases.
Table 1: Demographic Characteristics.
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Table 2: Lag Time from Symptom Onset to Presentation for Initial Evaluation and for Definitive
Treatment.
Patient related factors Freq. %
Ignorance of what it is 33 25.3
Finance 22 16.9






Painless/not disturbing her 9 6.9
Delayed by family and social
problems
9 6.9
Alternative and prayer house
treatment
7 5.4
Discouraged by friends and
relations
7 5.4




Trying to go abroad for treatment 2 1.5
On self medication, 2 1.5
Seeking different opinion 1 0.8
No confidence in the nearby
teaching hospital
1 0.8
Afraid of numerous protocols 1 0.8
Breastfeeding 1 0.8




Thought it is spiritual 1 0.8




Delay from treatment at the initial
hospital ,
delayed referrals or non referrals
23 17.8
Wrong advice, false reassurance
by Doctor/health personnel
15 11.5
Delay in histology report 8 6.2
No histology done after biopsy 7 5.4
Strike action at UNTH 6 4.6
On treatment by patent medicine
dealer
4 3.1
On treatment by a nurse 1 0.8
Repeated postponing in hospital 1 0.8
Table 3:
Table 4:
Stage of Disease at Presentation in Our
Hospital.
Reasons for Delay in Going to the First
Health Facility forTreatment.
Reason for delay b/w
symptom onset and 1st
modern treatment
Freq. Percent
Did not consider i t
serious/hope it will disappear 44 27.8
Ignorance of what it is 37 23.3
Finance 22 13.9
Using Alternative treatment or
prayer houses 20 12.6
Painless 19 12




Thought it is pregnancy/effect
of lactation 5 3.2
Discouraged by friends and
relations 5 3.2
Self medication 4 2.5
No reason 2 1.2
Searching for appropriate
hospital/doctor 2 1.3
Industrial action by Teach
hosp/lab test delay 2 1.3
Seeking different opinion 1 0.6
No ulcer 1 0.6
Fear she will die 1 0.6
Fear because her elder sister
had breast ca 1 0.6
A local nurse was treating her








Total 12 20 58 52 142
I II III IV
Total period
of delay One month or less 3 3 0 1 7
More than 1 month
But less than 3 months 4 3 7 0 14
3 months to 6 months 2 3 5 10 20
More than 6 months 3 11 46 41 101
Table 5: Factors That Play a Role in Causing
Significant Total Delay from Symptom Onset to
DefinitiveTreatment Point.
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where over 50% of the patients experience provider
delays of 6 months or more. Provider related delays
noted among our patients were principally of two
types (Table 5).
Most delays are from apparent deficits in
professional knowledge and practice in the
management of breast symptoms; including lack of
referrals or delayed referrals, false reassurances by
health personnel and failure to obtain histology after
biopsy. A less prominent but significant cause of
delay are from infrastructural and or organizational
lapses in health institutions causing delays in
diagnosis and treatment. Identified among such
factors are industrial actions by workers, absence of
water or light in hospitals hindering delivery of
services and non availability of needed facilities for
treatment or investigations. Improved professional
education, health institution reforms as well as
legislative and legal actions are measures that can be
used to shorten these provider related delays.
This study also shows that the causes of delay
between initial consultation and the definitive
treatment are more than provider related. Many of
the patients ignored or failed to follow up with their
referral and treatment for several reasons, including
failure to appreciate the potential danger of the breast
symptoms even after encounters with health
professionals, fear of surgery/mastectomy, lack of
funds and continued treatment with alternative
practitioners.
In a systematic analysis of studies of the influence of
delay on survival, Richards et al showed that patients
who delayed 3 months had a 12% lower 5-year
survival compared to those with shorter delays. Our
study showed that advanced stages of breast cancer
(stages III and IV) occurred significantly more
among patients whose total period of delay were
longer than three months. Similar findings have been
documented by other authors. It is thought that the
effect of delayed presentation on survival is mediated
through its influence on stage at diagnosis This
suggests that if adequate measures are taken to
shorten the total delay between onset of symptoms
and treatment of symptomatic breast disease,
survival from the disease can be improved.
Complex arrays of personal, social, and cultural
factors appear to influence a woman's decision to
delay before presentation. Among our patients, the
main reasons for delay before initial presentation
were patients low level of appreciation of
implications of beast symptoms, inability to afford
hospital care, patients use of alternative medicine and
prayer house treatments, fear of mastectomy,
patient's preoccupation with family, social and






These ranged from delayed referrals or non referrals
during treatment at the initial hospitals (17.8%),
wrong advice and false reassurances from the initial
doctor or health professional (11.5%), delays in
getting biopsy or histology reports (6.2%),
physician's failure to get biopsy or histology at the
initial evaluation (5.4%), and industrial actions in the
hospitals (4.6%).Delays from patient related factors
occurred in 79.2% of cases.
The main reasons here were patient claiming
ignorance of the dangers of the symptoms (25.3%) or
hoping that they will soon resolve (15.4%), lack of
funds to go for treatment (16.9%), patient's refusal or
fear of surgery and mastectomy (9.2%), delays from
family and social problems (6.9%), patients
believing that the symptom was not serious because
it was not painful and does not disturb her (6.9%) and
patients receiving treatment at alternative medical
practitioners and prayers houses (5.4%).
DISCUSSION
Most breast cancers in developing countries are
diagnosed at advanced stages resulting in limited
treatment options and poorer outcomes. The late
stage at diagnosis has often been assumed to be from
late presentation by the patients. This study shows
an exceptionally high prevalence of patient related
delays in presentation and equally long periods of
provider induced delays in referral and treatment. In
Britain, the time between the first symptom and start
of treatment is more than 3 months in about a third of
breast cancer patients, and more than 6 months in a
quarter. In our own patients, the time between
symptom onset and treatment is more than three
months in over 85% of the patients and more than 6
months in nearly 72% of the patients. Only 26.4% of
our patients sought their initial evaluation within one
month of onset of symptoms as opposed to more than
50% in Britian., 47% in Pakistan and 63% in India.
In developed countries, 20-30% of breast cancer
patients will delay for 3 months or more before
presentation; a duration that has been shown to be
significant because of the effect on survival. In
contrast, 45.3% of our patients delayed for 3 months
or more before presentation at their first point of
evaluation.
Nearly 73% of our patients had delays of over three
months from their first contact with health
institutions to the point of their definitive treatment.
In Britain only 6-16% of breast cancer patients
experience delays of more than 3 months between the
consultation of their family physician and referral to
hospital for definitive treatment. Such delays as this
are normally regarded as provider delays. While
some evidence exist that long provider delays do not
adversely influence survival if they are kept to within
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Among all the factors that we explored, only the
initial use of alternative practitioners and prayer
house treatment significantly increased the length of
delay before initial presentation. This is not
surprising considering that most cancer patients in
Nigeria use Complementary and Alternative
Medicine (CAM) with a curative intent.
Patients who commence their treatment with CAM
practitioners will only change to conventional
medicine when CAM fails them. Malik and Gopalan
reported a similar finding in Pakistan where use of
CAM was significantly associated with delay in
seeking medical advice and presentation at an
advanced stage of disease.
This study is based on patient's recall and patients
have been known to underreport delays to avoid
physician's criticism. Underreporting however will
only reduce the proportion of those with significant
delays so that our findings may actually be an
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